Search clinical trials for: GSK3008348

Total 5 results

Johns Hopkins University

Withdrawn

Diagnostic Utility of Amyl Nitrite in Patients With Suspected Achalasia Undergoing High Resolution Esophageal Manometry (HREM)

Dysphagia | Achalasia

United States
GlaxoSmithKline
Nucleus Network Ltd

Completed

Safety, Tolerability and Preliminary Pharmacokinetics (PK) and Pharmacodynamics (PD) of Single and Repeat Oral Doses of GSK3008356 in Healthy and Obese Subjects

Healthy Volunteers

Australia
GlaxoSmithKline

Terminated

Single Doses of GSK3008348 in Idiopathic Pulmonary Fibrosis (IPF) Participants Using Positron Emission Tomography (PET) Imaging

Idiopathic Pulmonary Fibrosis

United Kingdom
GlaxoSmithKline

Completed

First Time in Human (FTIH) Study of GSK3008348 in Healthy Volunteers and Idiopathic Pulmonary Fibrosis Patients

Idiopathic Pulmonary Fibrosis

United Kingdom
Novartis

Withdrawn

Safety of Phenylephrine Hydrochloride, Acetaminophen, Dimethindene Maleate Compared to Phenylephrine Hydrochloride Alone in Healthy Volunteers

Blood Pressure | Arrhythmias | Heart Rate

Brazil

3

Subscribe